AONN+ and Manta Cares Bring AI Cancer Tool to 9,000 Navigators

Two organizations focused on oncology care have joined forces to address a growing concern in cancer medicine: patients increasingly relying on general-purpose artificial intelligence tools for medical guidance. AONN+, a professional association for oncology navigators, and Manta Cares, a health technology company, announced a collaboration aimed at equipping more than 9,000 oncology nurse and patient navigators with AI resources purpose-built for cancer care.

The partnership centers on providing navigators with structured training, education, and access to AI tools specifically designed with cancer patients in mind — a deliberate contrast to broad consumer AI platforms not calibrated for complex oncological questions. Oncology navigators serve as critical intermediaries between patients and care teams, guiding individuals through diagnosis, treatment decisions, and support systems.

Read more Banner Capital to Acquire Three Plastics Firms, Form Seaway Group →

The agreement comes at a moment when the adoption of AI in patient-facing healthcare settings is accelerating. Health experts have raised concerns that general-purpose AI chatbots may provide incomplete, inaccurate, or insufficiently nuanced information to cancer patients facing high-stakes decisions, underscoring the need for purpose-built clinical tools vetted by medical professionals.

By channeling specialized AI resources through trained navigators rather than directly to patients, the AONN+-Manta Cares model positions human expertise as a filter and safeguard in the AI-assisted care process. The scale of the collaboration — spanning a navigator network of more than 9,000 professionals — signals an effort to standardize responsible AI use across a significant portion of the oncology navigation workforce nationwide.

Continue reading at GlobeNewswire - Industry News on Financial Services.